Iván Marcipar

1.1k total citations
78 papers, 870 citations indexed

About

Iván Marcipar is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Iván Marcipar has authored 78 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Epidemiology, 31 papers in Public Health, Environmental and Occupational Health and 18 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Iván Marcipar's work include Trypanosoma species research and implications (49 papers), Research on Leishmaniasis Studies (30 papers) and Viral Infections and Immunology Research (11 papers). Iván Marcipar is often cited by papers focused on Trypanosoma species research and implications (49 papers), Research on Leishmaniasis Studies (30 papers) and Viral Infections and Immunology Research (11 papers). Iván Marcipar collaborates with scholars based in Argentina, Sweden and Brazil. Iván Marcipar's co-authors include Cecilia Camussone, Claudia M. Lagier, Gabriel Cabrera, Luis M. Gugliotta, Luis F. Calvinho, Óscar Bottasso, Marı́a É. Ribone, Carolina Veaute, Verónica González and Ana Rosa Pérez and has published in prestigious journals such as Nature Communications, Analytical Biochemistry and Journal of Clinical Microbiology.

In The Last Decade

Iván Marcipar

75 papers receiving 857 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iván Marcipar Argentina 17 537 394 158 151 117 78 870
Juliana Felipetto Cargnelutti Brazil 17 329 0.6× 86 0.2× 89 0.6× 127 0.8× 96 0.8× 118 963
Eri Nakayama Japan 22 381 0.7× 451 1.1× 58 0.4× 132 0.9× 100 0.9× 56 1.3k
Élcio Leal Brazil 16 233 0.4× 154 0.4× 14 0.1× 119 0.8× 73 0.6× 92 976
Hee‐Bok Oh South Korea 16 193 0.4× 57 0.1× 93 0.6× 381 2.5× 66 0.6× 49 891
Faruku Bande Malaysia 14 117 0.2× 84 0.2× 93 0.6× 90 0.6× 63 0.5× 31 741
Jason Sawyer United Kingdom 18 188 0.4× 101 0.3× 66 0.4× 193 1.3× 47 0.4× 40 821
A. Rodríguez Spain 21 697 1.3× 1.1k 2.7× 386 2.4× 80 0.5× 149 1.3× 44 1.3k
Alejandro Castellanos-González United States 23 282 0.5× 161 0.4× 740 4.7× 295 2.0× 47 0.4× 44 1.3k
Mai thi Quynh Le Vietnam 13 377 0.7× 84 0.2× 42 0.3× 57 0.4× 93 0.8× 22 547

Countries citing papers authored by Iván Marcipar

Since Specialization
Citations

This map shows the geographic impact of Iván Marcipar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iván Marcipar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iván Marcipar more than expected).

Fields of papers citing papers by Iván Marcipar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iván Marcipar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iván Marcipar. The network helps show where Iván Marcipar may publish in the future.

Co-authorship network of co-authors of Iván Marcipar

This figure shows the co-authorship network connecting the top 25 collaborators of Iván Marcipar. A scholar is included among the top collaborators of Iván Marcipar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iván Marcipar. Iván Marcipar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pérez, Ana Rosa, et al.. (2026). Towards a map of the immune system manipulation network by Trypanosoma cruzi. Frontiers in Cellular and Infection Microbiology. 15. 1711520–1711520.
2.
Poncini, Carolina Verónica, et al.. (2024). Control of myeloid-derived suppressor cell dynamics potentiates vaccine protection in multiple mouse models of Trypanosoma cruzi infection. Frontiers in Immunology. 15. 1484290–1484290. 1 indexed citations
4.
Marcipar, Iván, et al.. (2023). Coupling ELISA to smartphones for POCT of chronic and congenital Chagas disease. Talanta. 256. 124246–124246. 7 indexed citations
5.
Ramsey, Janine M., Melissa S. Nolan, Jaime Altcheh, et al.. (2023). The Trypanosoma cruzi Antigen and Epitope Atlas: antibody specificities in Chagas disease patients across the Americas. Nature Communications. 14(1). 1850–1850. 16 indexed citations
6.
7.
Cabrera, Gabriel, et al.. (2022). Assessment of a combined treatment with a therapeutic vaccine and benznidazole for the Trypanosoma cruzi chronic infection. Acta Tropica. 229. 106334–106334. 13 indexed citations
9.
Lupi, Gabriele, Cecilia Langellotti, Valeria Quattrocchi, et al.. (2021). FMD empty capsids combined with the Immunostant Particle Adjuvant -ISPA or ISA206 induce protective immunity against foot and mouth disease virus. Virus Research. 297. 198339–198339. 16 indexed citations
10.
Gnazzo, Victoria, Cecilia Langellotti, Claudia Mongini, et al.. (2020). A New Cage-Like Particle Adjuvant Enhances Protection of Foot-and-Mouth Disease Vaccine. Frontiers in Veterinary Science. 7. 396–396. 8 indexed citations
11.
Cabrera, Gabriel & Iván Marcipar. (2019). Vaccines and the regulatory arm of the immune system. An overview from the Trypanosoma cruzi infection model. Vaccine. 37(28). 3628–3637. 13 indexed citations
13.
Buzzola, Fernanda R., et al.. (2015). Genotyping and study of the pauA and sua genes of Streptococcus uberis isolates from bovine mastitis. Revista Argentina de Microbiología. 47(4). 282–294. 15 indexed citations
14.
Camussone, Cecilia, María Sol Renna, Carolina Veaute, et al.. (2014). Immune response and functional role of antibodies raised in heifers against a Staphylococcus aureus CP5 lysate and recombinant antigens vaccine formulated with Iscom Matrix adjuvant. Veterinary Immunology and Immunopathology. 162(3-4). 96–107. 10 indexed citations
15.
16.
Gonzalez, Veronica D., et al.. (2012). Synthesis and characterization of carboxyl and acetal latexes by emulsion polymerization. Application to the production of latex-protein complexes for detecting chagas disease. Latin American Applied Research - An international journal. 42(4). 405–412. 4 indexed citations
17.
Camussone, Cecilia, et al.. (2012). Genotypic and phenotypic detection of capsular polysaccharides in Staphylococcus aureus isolated from bovine intramammary infections in Argentina.. Europe PMC (PubMed Central). 43(3). 1010–4. 18 indexed citations
18.
Valiente‐Gabioud, Ariel A., et al.. (2010). Effect of repetitiveness on the immunogenicity and antigenicity of Trypanosoma cruzi FRA protein. Experimental Parasitology. 127(3). 672–679. 22 indexed citations
19.
Velázquez, M.M.L., et al.. (2008). Trypanosoma cruzi: An analysis of the minicircle hypervariable regions diversity and its influence on strain typing. Experimental Parasitology. 120(3). 235–241. 15 indexed citations
20.
Gea, Susana, et al.. (2006). Cardiovascular risk factors in chronic Chagas' disease are associated with a different profile of putative heart-pathogenic antibodies. FEMS Immunology & Medical Microbiology. 48(1). 26–33. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026